Britain's AstraZeneca Plc said Friday it has formally filed a request for Japan's health ministry to approve its novel coronavirus vaccine, making it the second drugmaker to do so after U.S. pharmaceutical giant Pfizer Inc.The firm is seeking fast-track approval on the basis of trials held overseas and in Japan. A clinical study of the AstraZeneca vaccine developed with the University of Oxford began in Japan last August and the results of the domestic clinical study with 256 participants are expected to be submitted in March."It is my understanding that a decision will be made after the ef…READ FULL ARTICLE
